Skip to main content
. 2023 Nov 15;13(11):5455–5465.

Figure 2.

Figure 2

A. The mOS was 25.00 (95% CI 15.30-not reached) and 19.30 (95% CI 9.87-20.60) months; B. The mOS (VP3 and VP4) was 15.78 (95% CI 10.7-not reached) and 8.33 (95% CI 7.20-19.40) months; C. The mPFS was 21.74 (95% CI 10.01-not reached) and 8.74 (95% CI 6.34-13.60) months; D. The mDOR (mRecist) was not reached (95% CI 13.00-not reached) and 7.57 (95% CI 5.93-22.50) months. mOS: mean overall survival; mPFS: median progression-free survival; mDOR: median duration of response.